New Psychoactive Substances (NPS): Synthetic Stimulants/Synthetic Cannabinoids
ISSUP are pleased to present the First Webinar in a series on New Psychoactive Substances (NPS).
All Resources for 'Community-Based Prevention'
Peer to Peer User Guide-Drug and Alcohol Peer to Peer Prevention Program
This guide is developed to facilitate the work of Peer Counsellors in training Peer Educators in substance abuse prevention. It is based on the experience from the peer to peer drug prevention programs conducted by UYDEL. This peer to peer...
Severe bacterial infections in people who inject drugs: The role of injection-related tissue damage
Abstract
Background
In the context of the current U.S. injection drug use epidemic, targeted public health harm reduction strategies have traditionally focused on overdose prevention and reducing transmission of blood-borne viral...
Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial
Abstract
Background
Increasing buprenorphine/naloxone (B/N) access for opioid use disorder (OUD) is essential yet ensuring adherence and preventing diversion remains challenging. This study examines the feasibility, usability, and...
Fetal Exposure to Cannabis and Childhood Metabolic Outcomes: The Healthy Start Study
Abstract
Objective
To assess the impact of fetal exposure to cannabis on adiposity and glucose-insulin traits in early life.
Research Design and Methods
We leveraged a subsample of 103 mother-child pairs from Healthy Start, an...
Structural violence and the need for compassionate use of methadone in Mexico
Abstract
Background
Epidemiological data from Mexico have documented an increase in heroin use in the last decade. However, there is no comprehensive care strategy for heroin users, especially those who have been accused of a crime. The...
Prisons and drugs: health and social responses
This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide. It provides an overview of what to consider when planning or delivering health and social responses to drug...
Tailoring dissemination of evidence to preferences of tobacco control partners: results from an academic-community partnership
Background
Tobacco control program leaders may improve the use of evidence in program and policy development by presenting evidence to policymakers more often. However, current scientific knowledge regarding what works is slow to reach...
Neurofeedback for opioid dependent patients in an outpatient setting: a pilot feasibility study
Background
When used in combination with other therapies for drug use disorders, neurofeedback (NF) has been classified as "probably effective," according to recent research in the community of people with opioid use disorder. Despite...
Schools and drugs: health and social responses
A new handy mini guide by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) on evidence-based policymaking for prevention of drug use in schools and educational settings.
